EuroIntervention

Scope & Guideline

Exploring the Frontiers of Cardiovascular Medicine

Introduction

Welcome to your portal for understanding EuroIntervention, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1774-024x
PublisherEUROPA EDITION
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 2008 to 2024
AbbreviationEUROINTERVENTION / EuroIntervention
Frequency-
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address19 ALLEES JEAN JAURES B P 61508, TOULOUSE CEDEX 6 31015, FRANCE

Aims and Scopes

EuroIntervention focuses on advancing the field of interventional cardiovascular medicine, particularly through innovative techniques and devices for managing coronary and valvular heart diseases.
  1. Transcatheter Aortic Valve Implantation (TAVI):
    The journal frequently publishes studies on TAVI, exploring its effectiveness, complications, and advancements in valve technology.
  2. Percutaneous Coronary Intervention (PCI):
    Research on PCI techniques, including stenting, drug-coated balloons, and the management of complications, is a core focus area.
  3. Innovative Devices and Techniques:
    The journal highlights novel devices and methodologies, such as robotic assistance in procedures, and new stent technologies.
  4. Clinical Outcomes and Predictive Models:
    Studies assessing the long-term outcomes of various interventions and the development of predictive models for patient outcomes are prevalent.
  5. Antithrombotic Therapy:
    Exploration of antithrombotic strategies, including dual antiplatelet therapy (DAPT) and its implications in different patient populations.
  6. Valvular Heart Disease Interventions:
    Research on interventions for mitral and tricuspid valve diseases, including edge-to-edge repair techniques, is also prominent.
EuroIntervention has identified several emerging research themes that reflect the current trends in interventional cardiovascular medicine, driven by technological advancements and evolving clinical practices.
  1. Hybrid Approaches to Treatment:
    There is a growing interest in hybrid therapies that combine surgical and percutaneous methods, particularly in complex cases involving multi-valvular disease.
  2. Use of Artificial Intelligence (AI):
    AI applications in predicting outcomes, optimizing procedures, and enhancing imaging analysis are increasingly featured in recent publications.
  3. Patient-Centric Approaches:
    Research focusing on patient-reported outcomes, shared decision-making, and personalized treatment plans is on the rise, emphasizing the importance of patient preferences in clinical practice.
  4. Long-term Durability of Devices:
    Studies investigating the long-term performance and outcomes of newer devices, especially bioresorbable scaffolds and advanced stenting platforms, are gaining traction.
  5. Management of Non-Obstructive Coronary Artery Disease (MINOCA):
    An increasing number of studies are focusing on the diagnosis and management strategies for MINOCA, reflecting a shift towards understanding this complex condition.

Declining or Waning

While EuroIntervention continues to thrive in many areas, certain themes have seen a decline in prominence, reflecting shifts in clinical practice and research focus.
  1. Traditional Surgical Techniques:
    There has been a noticeable decrease in publications focused solely on traditional surgical interventions, as the field shifts towards less invasive, transcatheter approaches.
  2. Conventional Imaging Techniques:
    Research dedicated to older imaging modalities is waning in favor of advanced intravascular imaging techniques like optical coherence tomography (OCT) and intravascular ultrasound (IVUS).
  3. General Antithrombotic Guidelines:
    Specific guidelines that do not account for individual patient risk profiles are becoming less common, as personalized medicine approaches gain traction.
  4. Single Antiplatelet Therapy:
    There is a declining emphasis on the use of single antiplatelet therapy, especially in high-risk populations, with more focus on tailored DAPT strategies.
  5. Pharmacological Approaches in Isolation:
    Research that does not integrate procedural techniques with pharmacological management is becoming less frequent, as a more holistic approach is favored.

Similar Journals

Cardiology Journal

Championing open access to vital cardiology research.
Publisher: VIA MEDICAISSN: 1897-5593Frequency: 6 issues/year

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

Heart International

Connecting researchers and clinicians in the pursuit of heart health.
Publisher: TOUCH MEDICAL MEDIA LTDISSN: 2036-2579Frequency: 2 issues/year

Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.

JOURNAL OF CARDIAC SURGERY

Advancing cardiac care through groundbreaking research.
Publisher: WILEY-HINDAWIISSN: 0886-0440Frequency: 1 issue/year

The Journal of Cardiac Surgery, published by Wiley-Hindawi, stands as a pivotal resource in the fields of cardiology, cardiovascular medicine, and surgery, addressing critical developments and innovations in surgical techniques and patient management. Established in 1986, this esteemed journal has cultivated a reputation for nurturing high-quality research, as evidenced by its 2023 Scopus rankings, placing it in the top half for both Medicine: Surgery and Medicine: Cardiology and Cardiovascular Medicine. With an impact factor indicative of its influence in the scientific community, the journal is an essential platform for researchers, medical professionals, and students eager to stay abreast of advancements in cardiac surgery. Readers can access a range of original articles, reviews, and case studies that contribute significantly to our understanding of surgical practices and outcomes. As it converges towards its 2024 milestone, the journal continues to emphasize the importance of innovation in cardiac care, underscoring its commitment to improving patient outcomes worldwide.

JOURNAL OF INVASIVE CARDIOLOGY

Advancing the Frontiers of Invasive Cardiology
Publisher: H M P COMMUNICATIONSISSN: 1042-3931Frequency: 12 issues/year

JOURNAL OF INVASIVE CARDIOLOGY, a reputable publication by H M P COMMUNICATIONS, is dedicated to advancing the field of cardiology and cardiovascular medicine through rigorous research and scholarly discussion. With an ISSN of 1042-3931 and an E-ISSN of 1557-2501, this journal serves as a crucial resource for healthcare professionals, researchers, and students who seek to stay informed about the latest findings and innovations in invasive cardiology. Having achieved a 2023 Scopus rank of #185 out of 636 in General Medicine, placing it in the 70th percentile, the journal is recognized for its significant contributions to medical science, evidenced by its Q2 ranking in Radiology, Nuclear Medicine and Imaging, and Q3 status in both Cardiology and Cardiovascular Medicine. The journal has been in circulation since 1990 and continues to foster a platform for critical research in the United States, ensuring accessibility to vital information necessary for enhancing patient care and clinical practices within the domain of invasive procedures.

Journal fur Kardiologie

Unveiling the Latest in Cardiac Health Research.
Publisher: KRAUSE & PACHERNEGG GMBHISSN: 1024-0098Frequency: 12 issues/year

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Connecting Research and Practice in Cardiovascular Interventions
Publisher: WILEYISSN: 1522-1946Frequency: 14 issues/year

Catheterization and Cardiovascular Interventions is a leading peer-reviewed journal published by Wiley, dedicated to advancing the fields of cardiology, cardiovascular medicine, and radiology. With an impressive impact factor and categorized in the Q1 quartile across multiple disciplines—including Cardiology, Medicine, and Radiology—this journal serves as an essential resource for researchers, clinicians, and students interested in the latest developments in minimally invasive techniques and innovative cardiovascular therapies. Since its inception in 1999 and continuing through 2024, Catheterization and Cardiovascular Interventions has provided a platform for high-quality original research, reviews, and case studies, highlighting approaches that improve patient outcomes and treatment methodologies. Operating from the United States, the journal offers various access options, making key findings in cardiovascular interventions readily available to its audience. Stay at the forefront of cardiovascular innovation by engaging with this pivotal publication.

Heart Views

Exploring the future of heart health through shared knowledge.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1995-705XFrequency: 4 issues/year

Heart Views is a prestigious and influential journal dedicated to the field of cardiology and cardiovascular medicine, published by Wolters Kluwer Medknow Publications. With an Open Access model implemented since 2010, the journal ensures that its valuable research findings are accessible to a global audience, fostering knowledge dissemination and collaboration among researchers, professionals, and students alike. While the current impact factor is not specified, its commitment to quality and peer-reviewed content has established it as a significant resource within the cardiology community. The journal publishes a diverse array of articles, including original research, reviews, and clinical studies aimed at advancing the understanding and treatment of cardiovascular diseases. Heart Views serves as an essential platform for sharing innovative ideas and practices, thereby contributing to improved patient care and outcomes in the dynamic field of heart health.

CANADIAN JOURNAL OF CARDIOLOGY

Elevating Standards in Cardiovascular Research
Publisher: ELSEVIER SCIENCE INCISSN: 0828-282XFrequency: 12 issues/year

Canadian Journal of Cardiology (ISSN: 0828-282X, E-ISSN: 1916-7075), published by Elsevier Science Inc, serves as a vital platform for disseminating high-quality research in the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1985, this journal has established itself as a leader in the field, currently holding a prestigious Q1 ranking in Cardiology, indicating its significant impact and contribution to medical science. With a Scopus rank of #50 out of 387 in its category and placing in the 87th percentile, the journal showcases rigorous peer-reviewed articles that advance knowledge and practice in cardiology. Although the journal is not open access, it provides valuable insights and research findings that cater to clinicians, researchers, and students who are committed to improving cardiovascular health. As we approach the convergence of years to 2024, the Canadian Journal of Cardiology continues to strive for excellence, facilitating a discourse vital for both academic and clinical advancements in cardiology.

ACTA CARDIOLOGICA

Illuminating the path to better cardiovascular care.
Publisher: TAYLOR & FRANCIS LTDISSN: 0001-5385Frequency: 6 issues/year

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

CURRENT PROBLEMS IN CARDIOLOGY

Driving Progress in Heart Health Research
Publisher: MOSBY-ELSEVIERISSN: 0146-2806Frequency: 12 issues/year

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.